BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 15, 2001
View Archived Issues
Next 12 months predicted to be most productive period in BMS discovery and development history
Read More
Abbott terminates ABS-103 licensing agreement
Read More
Phytopharm's dementia treatment enters clinical testing
Read More
Phase Ib laboratory analysis complete of Helivax vaccine against H. pylori
Read More
Medarex and m-phasys collaborate on human antibody therapeutics development
Read More
Preclinical study supports use of Hemopure for acute blood loss following trauma
Read More
PRS-211095: a new neuroprotective dexanabinol analogue
Read More
Tolvaptan as an alternative to fluid restriction in hyponatremia
Read More
Primary endpoint reached in CART-1 trial of AGI-1067; data discussed in Anaheim
Read More
Phase II results of multigene DNA vaccine against malaria
Read More
Testosterone buccal tablet proves successful in phase III comparative trials
Read More
Active Biotech cleared to begin phase II trials of TTS in renal cell cancer
Read More
Development of VP-50406 discontinued for treatment of hepatitis C
Read More
Onco TCS pilot phase II trials expanded to include combination therapy with etoposide
Read More
AHA news: preliminary phase II data demonstrate significant increase in HDL cholesterol on JTT-705
Read More
Tezosentan in acute decompensated heart failure and acute coronary syndrome
Read More
Point Biomedical myocardial perfusion agent compares favorably to SPECT in phase II study
Read More
Antiarthritic agent with novel mechanism of action presented at ACR/ARHP meeting
Read More
Plenary VII: Late Breaking Clinical Trials webcast now available to DailyDrugNews.com readers
Read More
Sustained antiarthritic activity demonstrated in animal model for modified form of IL-1ra
Read More
Therapeutic potential of selective JNK inhibitor in epilepsy and stroke
Read More
General Hospital Corporation reveals novel method for treating neurodegenerative diseases
Read More
Cannabinoid antagonists claimed by Solvay for CNS, gastrointestinal and cardiovascular disorders
Read More
Ortho-McNeil synthesizes new calcium channel antagonists
Read More
Lipase inhibitors from Aventis useful for hyperlipidemia-related conditions
Read More
COX-2-inhibitory pyrazole derivatives identified at Pfizer
Read More
AtheroGenics patents VCAM-1 expression inhibitors and potential uses
Read More